Nordea Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $291M | Sell |
4,113,183
-13,852
| -0.3% | -$1.07M | 0.27% | 95 |
|
|
2025
Q4 | $328M | Sell |
4,127,035
-87,025
| -2% | -$6.86M | 0.28% | 93 |
|
|
2025
Q3 | $315M | Sell |
4,214,060
-126,984
| -3% | -$8.7M | 0.28% | 96 |
|
|
2025
Q2 | $298M | Sell |
4,341,044
-70,138
| -2% | -$4.6M | 0.28% | 101 |
|
|
2025
Q1 | $300M | Sell |
4,411,182
-800,042
| -15% | -$47.9M | 0.32% | 88 |
|
|
2024
Q4 | $234M | Sell |
5,211,224
-1,579,558
| -23% | -$88.6M | 0.24% | 111 |
|
|
2024
Q3 | $429M | Sell |
6,790,782
-540,096
| -7% | -$31.5M | 0.49% | 49 |
|
|
2024
Q2 | $438M | Sell |
7,330,878
-949,461
| -11% | -$59.4M | 0.51% | 43 |
|
|
2024
Q1 | $660M | Sell |
8,280,339
-719,589
| -8% | -$55M | 0.78% | 24 |
|
|
2023
Q4 | $711M | Sell |
8,999,928
-543,089
| -6% | -$38.7M | 0.9% | 22 |
|
|
2023
Q3 | $670M | Sell |
9,543,017
-298,811
| -3% | -$21.2M | 0.93% | 22 |
|
|
2023
Q2 | $678M | Sell |
9,841,828
-610,528
| -6% | -$43.4M | 0.93% | 21 |
|
|
2023
Q1 | $780M | Buy |
10,452,356
+1,180,537
| +13% | +$99M | 1.14% | 15 |
|
|
2022
Q4 | $863M | Buy |
9,271,819
+574,495
| +7% | +$55.4M | 1.34% | 11 |
|
|
2022
Q3 | $849M | Sell |
8,697,324
-983,166
| -10% | -$97.3M | 1.37% | 9 |
|
|
2022
Q2 | $900M | Buy |
9,680,490
+2,697,382
| +39% | +$263M | 1.34% | 8 |
|
|
2022
Q1 | $717M | Sell |
6,983,108
-1,844,748
| -21% | -$194M | 0.9% | 24 |
|
|
2021
Q4 | $912M | Sell |
8,827,856
-91,340
| -1% | -$8.44M | 1.09% | 16 |
|
|
2021
Q3 | $778M | Sell |
8,919,196
-266,696
| -3% | -$22.3M | 1.01% | 20 |
|
|
2021
Q2 | $766M | Buy |
9,185,892
+6,219
| +0.1% | +$509K | 1.03% | 20 |
|
|
2021
Q1 | $696M | Buy |
9,179,673
+55,685
| +0.6% | +$4.06M | 1.01% | 22 |
|
|
2020
Q4 | $623M | Buy |
9,123,988
+296,234
| +3% | +$19.3M | 1% | 20 |
|
|
2020
Q3 | $514M | Sell |
8,827,754
-9,690,890
| -52% | -$603M | 0.96% | 24 |
|
|
2020
Q2 | $1.19B | Buy |
18,518,644
+8,837,591
| +91% | +$557M | 1.23% | 18 |
|
|
2020
Q1 | $569M | Buy |
9,681,053
+108,587
| +1% | +$7.25M | 1.37% | 16 |
|
|
2019
Q4 | $708M | Sell |
9,572,466
-251,110
| -3% | -$17.6M | 1.41% | 14 |
|
|
2019
Q3 | $613M | Sell |
9,823,576
-1,175,093
| -11% | -$69.6M | 1.34% | 14 |
|
|
2019
Q2 | $600M | Sell |
10,998,669
-1,428,076
| -11% | -$76.9M | 1.34% | 16 |
|
|
2019
Q1 | $670M | Buy |
12,426,745
+340,315
| +3% | +$21M | 1.4% | 13 |
|
|
2018
Q4 | $792M | Buy |
12,086,430
+1,269,136
| +12% | +$94.7M | 1.88% | 6 |
|
|
2018
Q3 | $852M | Sell |
10,817,294
-581,118
| -5% | -$41.5M | 1.76% | 8 |
|
|
2018
Q2 | $733M | Sell |
11,398,412
-3,018,529
| -21% | -$199M | 1.76% | 8 |
|
|
2018
Q1 | $897M | Sell |
14,416,941
-71,607
| -0.5% | -$5.14M | 2.15% | 6 |
|
|
2017
Q4 | $1.05B | Buy |
14,488,548
+383,817
| +3% | +$27.9M | 2.48% | 3 |
|
|
2017
Q3 | $1.15B | Sell |
14,104,731
-50,191
| -0.4% | -$3.97M | 2.76% | 3 |
|
|
2017
Q2 | $1.14B | Buy |
14,154,922
+1,100,373
| +8% | +$86.9M | 2.87% | 3 |
|
|
2017
Q1 | $1.02B | Sell |
13,054,549
-231,722
| -2% | -$18.5M | 2.71% | 2 |
|
|
2016
Q4 | $1.05B | Buy |
13,286,271
+682,030
| +5% | +$55.2M | 2.77% | 4 |
|
|
2016
Q3 | $1.12B | Buy |
12,604,241
+959,810
| +8% | +$90.6M | 2.91% | 4 |
|
|
2016
Q2 | $1.11B | Buy |
11,644,431
+4,423,216
| +61% | +$441M | 3.12% | 2 |
|
|
2016
Q1 | $749M | Buy |
7,221,215
+2,017,610
| +39% | +$196M | 2.26% | 6 |
|
|
2015
Q4 | $509M | Buy |
5,203,605
+886,903
| +21% | +$86.9M | 1.73% | 12 |
|
|
2015
Q3 | $416M | Buy |
4,316,702
+525,086
| +14% | +$55.2M | 1.54% | 14 |
|
|
2015
Q2 | $398M | Buy |
3,791,616
+42,202
| +1% | +$4.31M | 1.39% | 19 |
|
|
2015
Q1 | $387M | Buy |
3,749,414
+224,157
| +6% | +$22.7M | 1.39% | 18 |
|
|
2014
Q4 | $340M | Buy |
3,525,257
+766,288
| +28% | +$67.5M | 1.25% | 21 |
|
|
2014
Q3 | $220M | Buy |
2,758,969
+206,831
| +8% | +$16.3M | 0.88% | 33 |
|
|
2014
Q2 | $192M | Sell |
2,552,138
-124,165
| -5% | -$9.38M | 0.8% | 33 |
|
|
2014
Q1 | $200M | Buy |
2,676,303
+135,932
| +5% | +$9.6M | 0.93% | 29 |
|
|
2013
Q4 | $182M | Buy |
2,540,371
+194,352
| +8% | +$12.5M | 0.91% | 29 |
|
|
2013
Q3 | $133M | Buy |
2,346,019
+707,448
| +43% | +$42.2M | 0.74% | 35 |
|
|
2013
Q2 | $93.7M | Buy |
+1,638,571
| New | +$94.9M | 0.58% | 45 |
|
Other funds holding CVS
VCM
VPM
Nordea Investment Management's CVS Position: Q1 2026 in Review
Nordea Investment Management reduced its CVS Health (CVS) stake by 0.34% in Q1 2026, selling an estimated $1.07M and leaving 4,113,183 shares worth $291M. The position accounts for 0.27% of the portfolio, ranked #95.
Nordea Investment Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.19B in Q2 2020. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Nordea Investment Management held 4,113,183 shares of CVS Health worth $291M as of Q1 2026.
- Nordea Investment Management sold 13,852 CVS Health shares in Q1 2026, an estimated $1.07M.
- CVS Health made up 0.27% of Nordea Investment Management's portfolio in Q1 2026, its #95 holding.
- Nordea Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Nordea Investment Management's CVS Health position peaked at $1.19B in Q2 2020.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.